Xenotransplantation: An ethical dilemma

Current Opinion in Cardiology

Volumn 21, Issue 2, 2006, Pages 138-141

  George, James F ^a  

^a Kentucky   (United States)

Author keywords

Donor organs; Ethics; Genetically manipulated pigs; Safeguards; Xenotransplantation

Indexed keywords

CARDIAC GRAFT REJECTION; CLINICAL PRACTICE; DNA MODIFICATION; EXTRACORPOREAL CIRCULATION; HEART TRANSPLANTATION; HUMAN; LABORATORY; LEGAL ASPECT; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL SOCIETY; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR; XENOTRANSPLANTATION;

ANIMAL RIGHTS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ETHICS, MEDICAL; HEART TRANSPLANTATION; HUMANS; RISK ASSESSMENT; SWINE; TISSUE DONORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33745113338     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000203183.81534.f9     Document Type: Review

References (55)

1. Ezzelarab M, Ayares D, Cooper DK. Carbohydrates in xenotransplantation. Immunol Cell Biol 2005; 83:396-404.
2. Ahn C, Kim JY, Lee BC, et al. The past, present, and future of xenotransplantation. Yonsei Med J 2004; 45:1017-1024.
3. Cooper DK, Tseng YL, Saidman SL. Alloantibody and xenoantibody cross-reactivity in transplantation. Transplantation 2004; 77:1-5.
4. Hansen AK, Dahl K, Sorensen DB, et al. Xenotransplantation: state of the art. Acta Vet Scand Suppl 2004; 99:7-12.
5. Khalpey Z, Koch CA, Platt JL. Xenograft transplantation. Anesthesiol Clin North America 2004; 22:871-885.
6. Ogata K, Platt JL. Cardiac xenotransplantation: future and limitations. Cardiology 2004; 101:144-155.
7. Cooper DK, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7:238-246.
8. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A 1993; 90:11391-11395.
9. Dabkowski PL, Vaughan HA, McKenzie IF, Sandrin MS. Characterisation of a cDNA clone encoding the pig alpha 1,3 galactosyltransferase: implications for xenotransplantation. Transplant Proc 1993; 25:2921.
10. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF. Studies on human naturally occurring antibodies to pig xenografts. Transplant Proc 1993; 25:2917-2918.
11. Cooper DK, Good AH, Koren E, et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993; 1:198-205.
12. Galili U, Shohet SB, Kobrin E, et al. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263:17755-17762.
13. Alwayn IP, Basker M, Buhler L, Cooper DK. The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies. Xenotransplantation 1999; 6:157-168.
14. Kobayashi T, Taniguchi S, Neethling FA, et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64:1255-1261.
15. Pierson RN III, Kasper-Konig W, Tew DN, et al. Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement. Transplantation 1997; 63:594-603.
16. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55:857-865.
17. Knechtle SJ, Halperin EC, Murphy CE, et al. The effect of cyclosporine, total lymphoid irradiation, and cobra venom factor on hyperacute rejection. J Heart Transplant 1985; 4:541-545.
18. Cozzi E, Langford GA, Richards A, et al. Expression of human decay accelerating factor in transgenic pigs. Transplant Proc 1994; 26:1402-1403.
19. Fodor WL, Williams BL, Matis LA, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci U S A 1994; 91:11153-11157.
20. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299:411-414.
21. Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295:1089-1092.
22. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 2004; 101:7335-7340.
23. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11:29-31. A validation of the strategy of producing engineered pigs to overcome hyperacute rejection.
24. Komoda H, Miyagawa S, Omori T, et al. Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys. Xenotransplantation 2005; 12:209-216.
25. Valdes-Gonzalez RA, Dorantes LM, Garibay GN, et al. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur J Endocrinol 2005; 153:419-427.
26. Takahagi Y, Fujimura T, Miyagawa S, et al. Production of alpha 1,3-galactosyltransferase gene knockout pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III. Mol Reprod Dev 2005; 71:331-338.
27. Fujimura T, Kurome M, Murakami H, et al. Cloning of the transgenic pigs expressing human decay accelerating factor and N-acetylglucosaminyltransferase III. Cloning Stem Cells 2004; 6:294-301.
28. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254:3321-3329.
29. Franklin D. Baboon-to-human transplant draws mixed reviews. Sci News 1984; 126:276.
30. Dommel FW. The NIH report of its review of the Baby Fae case. IRB 1986; 8:1-4.
31. Hubbard LL. The Baby Fae case. Med Law 1987; 6:385-396.
32. Caplan AL. Ethical issues raised by research involving xenografts. JAMA 1985; 254:3339-3343.
33. Rosner F. Artificial and baboon heart implantation: the Jewish view. Arch Intern Med 1985; 145:1330.
34. Annas GJ. Baby Fae: the 'anything goes' school of human experimentation. Hastings Cent Rep 1985; 15:15-17.
35. Sykes M, d'Apice A, Sandrin M. Position paper of the Ethics Committee of the International Xenotransplantation Association. Xenotransplantation 2003; 10:194-203.
36. Cooke DT, Caffarelli AD, Robbins RC. The road to clinical xenotransplantation: a worthwhile journey. Transplantation 2004; 78:1108-1109.
37. Weiss RA. Cross-species infections. Curr Top Microbiol Immunol 2003; 278:47-71.
38. Fee E, Brown TM, Lazarus J, Theerman P. The influenza pandemic of 1918. Am J Public Health 2001; 91:1953.
39. Peiris JS. Severe acute respiratory syndrome (SARS). J Clin Virol 2003; 28:245-247.
40. Pourrut X, Kumulungui B, Wittmann T, et al. The natural history of Ebola virus in Africa. Microbes Infect 2005; 7:1005-1014.
41. Ligon BL. Outbreak of Marburg hemorrhagic fever in Angola: a review of the history of the disease and its biological aspects. Semin Pediatr Infect Dis 2005; 16:219-224.
42. Centers for Disease Control and Prevention. U.S. public health service guideline on infectious disease issues in xenotransplantation. MMWR Recomm Rep 2001; 50:1-47.
43. Patience C, Scobie L, Quinn G. Porcine endogenous retrovirus: advances, issues and solutions. Xenotransplantation 2002; 9:373-375.
44. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3:282-286.
45. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 2004; 4:1383-1390.
46. Winkler ME, Winkler M, Burian R, et al. Analysis of pig-to-human porcine endogenous retrovirus transmission in a triple-species kidney xenotransplantation model. Transpl Int 2005; 17:848-858.
47. Ravelingien A, Braeckman J. To the core of porcine matter: evaluating arguments against producing transgenic pigs. Xenotransplantation 2004; 11:371-375. Discusses two types of ethical arguments, consequentialist and inherent, against using or making transgenic pigs. Concludes that the arguments are not valid and should be restricted to practical concerns.
48. Robert JS, Baylis F. Crossing species boundaries. Am J Bioeth 2003; 3:1-13.
49. Ravelingien A. Use of pigs for xenotransplantation: the speciesism by proxy syndrome. Xenotransplantation 2005; 12:235-239.
50. Wright JR Jr. Public consultation on xenotransplantation. Transplantation 2004; 78:1112-1113.
51. Ivinson AJ, Bach FH. The xenotransplantation question: public consultation is an important part of the answer. CMAJ 2002; 167:42-43.
52. Wright JR Jr. Alternative interpretations of the same data: flaws in the process of consulting the Canadian public about xenotransplantation issues. CMAJ 2002; 167:40-42.
53. Bach FH, Ivinson AJ, Weeramantry C. Ethical and legal issues in technology: xenotransplantation. Am J Law Med 2001; 27:283-300.
54. Bowman DM. Bioethical and legal perspectives on xenotransplantation. Monash Bioeth Rev 2004; 23:16-29.
55. Incorvati G. Xenotransplantation, public responsibility and law. Eur J Health Law 2003; 10:295-304.